EYBELIS Trademark

Trademark Overview


On Wednesday, June 14, 2017, a trademark application was filed for EYBELIS with the United States Patent and Trademark Office. The USPTO has given the EYBELIS trademark a serial number of 79219543. The federal status of this trademark filing is REGISTERED as of Tuesday, August 28, 2018. This trademark is owned by Santen Pharmaceutical Co., Ltd.. The EYBELIS trademark is filed in the Pharmaceutical Products category with the following description:

Collyrium; eye drops; ophthalmological preparations; pharmaceutical preparations for treatment of cataracts; pharmaceutical preparations for treatment of glaucoma; pharmaceutical preparations for treatment of ocular hypertension; ophthalmic ointments for the treatment of eye diseases and conditions; pharmaceutical preparations for use in eye injections for the treatment of eye diseases and conditions; pharmaceutical preparations for treatment of pinguecula; pharmaceutical preparations for treatment of chalazion; pharmaceutical preparations for treatment of uveitis; eye drops for treatment of cornea conjunctiva epithelium disorder; antibacterial eye drops; antiallergic eye drops; pharmaceutical preparations for the treatment of eye diseases and conditions; reagent paper for medical purposes; oiled paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for medical use; capsules for medicines, namely, capsules sold empty ...
eybelis

General Information


Serial Number79219543
Word MarkEYBELIS
Filing DateWednesday, June 14, 2017
Status700 - REGISTERED
Status DateTuesday, August 28, 2018
Registration Number5547903
Registration DateTuesday, August 28, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 12, 2018

Trademark Statements


Goods and ServicesCollyrium; eye drops; ophthalmological preparations; pharmaceutical preparations for treatment of cataracts; pharmaceutical preparations for treatment of glaucoma; pharmaceutical preparations for treatment of ocular hypertension; ophthalmic ointments for the treatment of eye diseases and conditions; pharmaceutical preparations for use in eye injections for the treatment of eye diseases and conditions; pharmaceutical preparations for treatment of pinguecula; pharmaceutical preparations for treatment of chalazion; pharmaceutical preparations for treatment of uveitis; eye drops for treatment of cornea conjunctiva epithelium disorder; antibacterial eye drops; antiallergic eye drops; pharmaceutical preparations for the treatment of eye diseases and conditions; reagent paper for medical purposes; oiled paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for medical use; capsules for medicines, namely, capsules sold empty for pharmaceuticals and drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton, namely, cotton for medical purposes and cotton sticks for medical purposes, antiseptic cotton; adhesive plasters, namely, adhesive plasters for medical purposes, sticking plasters for medical purposes and medical and surgical plasters; bandages for dressings; liquid bandages, namely, antiseptic liquid bandages, liquid bandage sprays and liquid bandages for skin wounds; breast-nursing pads; cotton sticks for medical purposes; incontinence diapers; diapers; diaper covers, namely, inserts specially adapted for cloth infant diapers made of microfiber and infant diaper covers of textile; dietary supplements for humans; nutritional supplements; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies, namely, infant formula and meal replacement beverages for babies adapted for medical use; food for babies; dietary supplements for animals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 30, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSanten Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameSanten Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameSanten Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Monday, August 28, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, May 1, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, January 5, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, December 13, 2018FINAL DISPOSITION NOTICE SENT TO IB
Thursday, December 13, 2018FINAL DISPOSITION PROCESSED
Wednesday, November 28, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 28, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, June 12, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 12, 2018PUBLISHED FOR OPPOSITION
Friday, June 8, 2018NOTIFICATION PROCESSED BY IB
Wednesday, May 23, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 23, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 23, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Monday, May 7, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 25, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 16, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 16, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 12, 2018ASSIGNED TO LIE
Tuesday, April 3, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, November 25, 2017REFUSAL PROCESSED BY IB
Thursday, November 9, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, November 9, 2017REFUSAL PROCESSED BY MPU
Friday, November 3, 2017APPLICATION FILING RECEIPT MAILED
Wednesday, November 1, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, October 31, 2017NON-FINAL ACTION WRITTEN
Tuesday, October 31, 2017NON-FINAL ACTION WRITTEN
Monday, October 30, 2017ASSIGNED TO EXAMINER
Monday, October 30, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 26, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB